Literature DB >> 27286936

β-endorphin regulates alcohol consumption induced by exercise restriction in female mice.

Colleen E McGonigle1, Todd B Nentwig1, Diane E Wilson2, Erin M Rhinehart2, Judith E Grisel3.   

Abstract

Animal models have long been used to study the mechanisms underlying the complex association between alcohol and stress. Female mice prevented from running on a home-cage activity wheel increase voluntary ethanol consumption. β-endorphin is an endogenous opioid involved in negatively regulating the stress response and has also been implicated in the risk for excessive drinking. The present study investigates the role of β-endorphin in moderating free-choice consumption of ethanol in response to a blocked activity wheel. Female, transgenic mice with varying levels of the opioid peptide were given daily 2-h access to 20% ethanol with rotations on a running wheel blocked on alternate days. Subjects with low β-endorphin exhibited enhanced stress sensitivity by self-administering larger quantities of ethanol on days when wheel running was prevented. β-endorphin levels did not influence voluntary activity on the running wheel. There were genotypic differences in plasma corticosterone levels as well as corticotropin-releasing hormone mRNA content in multiple brain regions associated with the stress response in these free drinking and running subjects. Susceptibility to stress is enhanced in female mice with low levels of β-endorphin, and better understanding of the role for this opioid in mitigating the response to stressors may aid in the development of interventions and treatments for excessive use of alcohol in women.
Copyright © 2016 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Corticosterone; Crh; Ethanol self-administration; Exercise; Opioid; Stress

Mesh:

Substances:

Year:  2016        PMID: 27286936      PMCID: PMC4903156          DOI: 10.1016/j.alcohol.2016.04.003

Source DB:  PubMed          Journal:  Alcohol        ISSN: 0741-8329            Impact factor:   2.405


  56 in total

1.  Family history of alcoholism and hypothalamic opioidergic activity.

Authors:  G S Wand; D Mangold; S El Deiry; M E McCaul; D Hoover
Journal:  Arch Gen Psychiatry       Date:  1998-12

2.  Gene-targeting studies: new methods, old problems.

Authors:  W E Crusio
Journal:  Trends Neurosci       Date:  1996-05       Impact factor: 13.837

3.  A runner's high depends on cannabinoid receptors in mice.

Authors:  Johannes Fuss; Jörg Steinle; Laura Bindila; Matthias K Auer; Hartmut Kirchherr; Beat Lutz; Peter Gass
Journal:  Proc Natl Acad Sci U S A       Date:  2015-10-05       Impact factor: 11.205

Review 4.  Effects of opioids on the hypothalamo-pituitary-adrenal axis.

Authors:  R N Pechnick
Journal:  Annu Rev Pharmacol Toxicol       Date:  1993       Impact factor: 13.820

Review 5.  Stress and health: major findings and policy implications.

Authors:  Peggy A Thoits
Journal:  J Health Soc Behav       Date:  2010

6.  Mouse inbred strain differences in ethanol drinking to intoxication.

Authors:  J S Rhodes; M M Ford; C-H Yu; L L Brown; D A Finn; T Garland; J C Crabbe
Journal:  Genes Brain Behav       Date:  2007-02       Impact factor: 3.449

7.  Sex and depression in the National Comorbidity Survey. I: Lifetime prevalence, chronicity and recurrence.

Authors:  R C Kessler; K A McGonagle; M Swartz; D G Blazer; C B Nelson
Journal:  J Affect Disord       Date:  1993 Oct-Nov       Impact factor: 4.839

Review 8.  Amygdala and bed nucleus of the stria terminalis circuitry: Implications for addiction-related behaviors.

Authors:  Alice M Stamatakis; Dennis R Sparta; Joshua H Jennings; Zoe A McElligott; Heather Decot; Garret D Stuber
Journal:  Neuropharmacology       Date:  2013-06-07       Impact factor: 5.250

9.  GABAergic Signaling within a Limbic-Hypothalamic Circuit Integrates Social and Anxiety-Like Behavior with Stress Reactivity.

Authors:  Brent Myers; Eduardo Carvalho-Netto; Dayna Wick-Carlson; Christine Wu; Sam Naser; Matia B Solomon; Yvonne M Ulrich-Lai; James P Herman
Journal:  Neuropsychopharmacology       Date:  2015-10-07       Impact factor: 7.853

10.  Alcohol exposure during the developmental period induces beta-endorphin neuronal death and causes alteration in the opioid control of stress axis function.

Authors:  Dipak K Sarkar; Peter Kuhn; Jasson Marano; Cuiping Chen; Nadka Boyadjieva
Journal:  Endocrinology       Date:  2007-03-08       Impact factor: 4.736

View more
  5 in total

1.  The neurobiological markers of acute alcohol's subjective effects in humans.

Authors:  Raphael Hamel; Olivier Demers; Camille Boileau; Marie-Laurence Roy; Hugo Théoret; Pierre-Michel Bernier; Jean-Francois Lepage
Journal:  Neuropsychopharmacology       Date:  2022-06-14       Impact factor: 8.294

2.  The impact of intermittent exercise on mouse ethanol drinking and abstinence-associated affective behavior and physiology.

Authors:  Samuel W Centanni; Sara Y Conley; Joseph R Luchsinger; Louise Lantier; Danny G Winder
Journal:  Alcohol Clin Exp Res       Date:  2021-11-23       Impact factor: 3.928

3.  Sex differences and the lack of effects of chemogenetic manipulation of pro-opiomelanocortin (POMC) neurons on alcohol consumption in male and female mice.

Authors:  Jonna M Leyrer-Jackson; Lauren E Hood; M Foster Olive
Journal:  Brain Res       Date:  2022-03-31       Impact factor: 3.610

4.  Sex differences in binge-like EtOH drinking, corticotropin-releasing hormone and corticosterone: effects of β-endorphin.

Authors:  Todd B Nentwig; Diane E Wilson; Erin M Rhinehart; Judith E Grisel
Journal:  Addict Biol       Date:  2018-02-08       Impact factor: 4.280

Review 5.  The IntelliCage System: A Review of Its Utility as a Novel Behavioral Platform for a Rodent Model of Substance Use Disorder.

Authors:  Ismail Nurul Iman; Nurul Aiman Mohd Yusof; Ummi Nasrah Talib; Nur Aimi Zawami Ahmad; Anwar Norazit; Jaya Kumar; Muhammad Zulfadli Mehat; Nanthini Jayabalan; Sangu Muthuraju; Marzena Stefaniuk; Leszek Kaczmarek; Mustapha Muzaimi
Journal:  Front Behav Neurosci       Date:  2021-06-04       Impact factor: 3.558

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.